2026 NPPES data Ophthalmic Plastic and Reconstructive Surgery Physician NPI 1225327240 MD
Verify on CMS →

LAMISE RAJJOUB, MD

Ophthalmic Plastic and Reconstructive Surgery Physician in WASHINGTON, District of Columbia. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
373
Medicare Part D claims · 160 beneficiaries · Ophthalmic Plastic and Reconstructive Surgery Physician avg: 624
Generic prescribing
66%
generic claims · 34% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$12.6K
27 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: LAMISE RAJJOUB, MD is a Ophthalmic Plastic and Reconstructive Surgery Physician ([object Object]) practicing in WASHINGTON, District of Columbia with a Medicare Part D prescribing footprint of 373 claims across 160 beneficiaries — 34% brand-name prescribing . Industry payments of $12.6K across 27 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: LAMISE RAJJOUB, MD filed 373 Medicare Part D claims in 2023 across WASHINGTON, District of Columbia. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

LAMISE RAJJOUB, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

LAMISE RAJJOUB, MD at a glance

Quality data not reported

NPI registry status

Active

Issued 03/30/2011

NPI 1225327240

Primary specialty

Ophthalmic Plastic and Reconstructive Surgery Physician

Rare

291 US NPIs in this specialty

Medicare Part D claims

373 40% vs specialty avg

2023 prescription claims

Specialty avg: 624

Specialty distribution in District of Columbia

How Ophthalmic Plastic and Reconstructive Surgery Physician compares to other specialties among District of Columbia providers

District of Columbia providers

Ophthalmic Plastic and Reconstructive Surgery Physician share within District of Columbia

1. Ophthalmic Plastic and Reconstructive Surgery Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Ophthalmic Plastic and Reconstructive Surgery Physician share within District of Columbia

Specialty board-certification context

Estimated specialty board-certified rate — Ophthalmic Plastic and Reconstructive Surgery Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Ophthalmic Plastic and Reconstructive Surgery Physician ABMS/AOA estimate

Est. board-certified rate (Ophthalmic Plastic and Reconstructive Surgery Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Ophthalmic Plastic and Reconstructive Surgery Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

LAMISE RAJJOUB, MD is a Ophthalmic Plastic and Reconstructive Surgery Physician provider practicing in WASHINGTON, District of Columbia, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1225327240. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

LAMISE RAJJOUB, MD appears in the CMS NPPES registry as a Ophthalmic Plastic and Reconstructive Surgery Physician provider holding MD credentials at 2150 PENNSYLVANIA AVE NW, WASHINGTON, DC, 20037, with a listed phone of (202) 741-3000. NPI 1225327240 was issued on 03/30/2011. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what RAJJOUB most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 373 prescription claims written by this provider, covering 160 Medicare beneficiaries and totaling roughly $68K in drug spend, split 34% brand-name and 66% generic by claim count, with an opioid prescribing rate of 10.5%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Ophthalmic Plastic and Reconstructive Surgery Physician is a narrow specialty nationwide, with 291 enrolled providers across 46 states and an average of 624 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2150 PENNSYLVANIA AVE NW
WASHINGTON, DC 20037

Provider Details

NPI 1225327240
Specialty Ophthalmic Plastic and Reconstructive Surgery Physician
Credentials MD
Gender Female
NPI Issued 03/30/2011

Hospital and facility affiliations

Facilities where LAMISE RAJJOUB, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

ANH NGUYEN MD, PC
FALLS CHURCH, VA
MEDICAL FACULTY ASSOCIATES, INC
WASHINGTON, DC

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for LAMISE RAJJOUB, MD. Source: openpaymentsdata.cms.gov.

Total received

$12.6K

Largest payer

Amgen Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

LAMISE RAJJOUB, MD — brand share 34.0%
Specialty average (est.)

34% brand-name claims vs 66% generic, on 373 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

373
Total Claims
$68K
Total Drug Cost
160
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
397
Total Day Supply
5,505
Brand vs Generic
34% brand / 66% generic
Brand Drug Cost
$62K
Generic Drug Cost
$6K
Opioid Claims
39 (10.5% rate)
Antibiotic Claims
34

Patient Demographics

Average Patient Age
75.8 years
Avg HCC Risk Score
0.98
Gender Split
66% female / 34% male
Age Distribution
<65: 0, 65-74: 78, 75-84: 66, 85+: 16

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Neomycin-Polymyxin-Dexameth
Neomycin/Polymyxin B/Dexametha
149
Tobramycin-Dexamethasone
Tobramycin/Dexamethasone
44
Acetaminophen-Codeine
Acetaminophen With Codeine
24
Erythromycin
Erythromycin Base
24
Doxycycline Hyclate
17
Tramadol Hcl
15
Moxifloxacin
Moxifloxacin Hcl
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Ophthalmic Plastic and Reconstructive Surgery Physician Overview

How LAMISE RAJJOUB, MD fits within the Ophthalmic Plastic and Reconstructive Surgery Physician landscape nationally.

291
Ophthalmic Plastic and Reconstructive Surgery Physician Providers in US
46
States with Ophthalmic Plastic and Reconstructive Surgery Physician
624
Avg Claims per Provider

LAMISE RAJJOUB, MD's 373 claims are below the specialty average of 624.

Frequently Asked Questions

What is LAMISE RAJJOUB, MD's specialty?
LAMISE RAJJOUB, MD specializes in Ophthalmic Plastic and Reconstructive Surgery Physician and practices in WASHINGTON, District of Columbia. Credentials: MD.
How much does LAMISE RAJJOUB, MD prescribe under Medicare Part D?
In 2023, LAMISE RAJJOUB, MD wrote 373 Medicare Part D claims totaling $68K in drug costs for 160 beneficiaries.
Where is LAMISE RAJJOUB, MD located?
LAMISE RAJJOUB, MD is located at 2150 PENNSYLVANIA AVE NW, WASHINGTON, DC, 20037. Phone: (202) 741-3000.
What is LAMISE RAJJOUB, MD's NPI number?
LAMISE RAJJOUB, MD's National Provider Identifier (NPI) is 1225327240, issued on 03/30/2011.
Does LAMISE RAJJOUB, MD prescribe more brand-name or generic drugs?
LAMISE RAJJOUB, MD's prescribing is 34% brand-name and 66% generic drugs by claim count, with $62K in brand drug costs.
Does LAMISE RAJJOUB, MD prescribe opioids?
Yes, LAMISE RAJJOUB, MD had 39 opioid claims in 2023 with an opioid prescribing rate of 10.5%.
How many Ophthalmic Plastic and Reconstructive Surgery Physician providers are there in the US?
There are 291 Ophthalmic Plastic and Reconstructive Surgery Physician providers across 46 states in the US. The average Ophthalmic Plastic and Reconstructive Surgery Physician provider writes 624 Medicare Part D claims per year.
What drugs does LAMISE RAJJOUB, MD prescribe most often?
Based on 2023 Medicare Part D data, LAMISE RAJJOUB, MD's most frequently prescribed drugs include Neomycin-Polymyxin-Dexameth, Tobramycin-Dexamethasone, Acetaminophen-Codeine. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does LAMISE RAJJOUB, MD accept Medicare?
LAMISE RAJJOUB, MD appears in CMS Medicare data with 373 Part D claims and 160 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify LAMISE RAJJOUB, MD's credentials?
LAMISE RAJJOUB, MD's NPI is 1225327240 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology